KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Capital Expenditures (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.90%
Dec 31, 2025 47.25%
Sep 30, 2025 18.16%
Jun 30, 2025 -10.22%
Mar 31, 2025 10.78%
Dec 31, 2024 44.36%
Sep 30, 2024 7.98%
Jun 30, 2024 3.48%
Mar 31, 2024 -7.63%
Dec 31, 2023 0.40%
Sep 30, 2023 -8.49%
Jun 30, 2023 -21.22%
Mar 31, 2023 1.18%
Dec 31, 2022 112.50%
Sep 30, 2022 -34.96%
Jun 30, 2022 29.47%
Mar 31, 2022 -33.80%
Dec 31, 2021 18.60%
Sep 30, 2021 30.81%
Jun 30, 2021 11.45%
Mar 31, 2021 -4.05%
Dec 31, 2020 28.15%
Sep 30, 2020 -14.56%
Jun 30, 2020 11.27%
Mar 31, 2020 -24.47%
Dec 31, 2019 10.59%
Sep 30, 2019 18.06%
Jun 30, 2019 24.14%
Mar 31, 2019 -48.44%
Dec 31, 2018 31.58%
Sep 30, 2018 -8.56%
Jun 30, 2018 20.65%
Mar 31, 2018 1.31%
Dec 31, 2017 -3.16%
Sep 30, 2017 -14.59%
Jun 30, 2017 10.12%
Mar 31, 2017 -25.99%
Dec 31, 2016 35.93%
Sep 30, 2016 -11.17%
Jun 30, 2016 20.51%
Mar 31, 2016 -23.90%
Dec 31, 2015 48.55%
Sep 30, 2015 3.76%
Jun 30, 2015 12.71%
Mar 31, 2015 -41.87%
Dec 31, 2014 19.41%
Sep 30, 2014 -1.73%
Jun 30, 2014 0.58%
Mar 31, 2014 -14.43%
Dec 31, 2013 14.86%
Sep 30, 2013 10.06%
Jun 30, 2013 0.63%
Mar 31, 2013 -21.00%
Dec 31, 2012 15.61%
Sep 30, 2012 0.58%
Jun 30, 2012 19.44%
Mar 31, 2012 -35.71%
Dec 31, 2011 86.67%
Sep 30, 2011 -2.44%
Jun 30, 2011 23.00%
Mar 31, 2011 -45.05%
Dec 31, 2010 43.31%
Sep 30, 2010 -28.25%
Jun 30, 2010 88.30%
Mar 31, 2010 -34.72%
Dec 31, 2009 10.77%
Sep 30, 2009 -6.47%
Jun 30, 2009 18.80%